Product Description
Bevacizumab Biosimilar 100mg Injection is a targeted monoclonal antibody therapy widely used in the treatment of various cancers, including colorectal cancer, lung cancer, kidney cancer, and glioblastoma. Manufactured and exported by Cordium Pharmaceuticals Pvt Ltd, this biosimilar ensures high efficacy, safety, and affordability for global patients.
Cordium Pharmaceuticals is a leading exporter from India, recognized for delivering premium oncology medicines with fast and reliable international shipping.
Key Benefits of Bevacizumab Biosimilar 100mg Injection
Helps inhibit tumor blood vessel growth (anti-angiogenesis)
Improves survival rates in multiple cancer therapies
WHO-GMP compliant manufacturing standards
Cost-effective alternative to branded Bevacizumab
Trusted quality with global export certifications
Therapeutic Uses
Bevacizumab Biosimilar 100mg Injection is commonly prescribed for:
Metastatic colorectal cancer
Non-small cell lung cancer
Glioblastoma (brain tumors)
Renal cell carcinoma (kidney cancer)
Cervical cancer
Global Export & Fast Shipping
Cordium Pharmaceuticals Pvt Ltd ensures quick and secure delivery worldwide, including:
USA: Washington, New York, San Francisco
United Kingdom (UK): London, Birmingham, Manchester
Asia: Philippines, Singapore
Middle East: Dubai, Abu Dhabi, Oman, Qatar
Africa: South Africa
North America: Canada
We specialize in temperature-controlled packaging and express international logistics to maintain product integrity.
Why Choose Cordium Pharmaceuticals Pvt Ltd?
Leading oncology medicine exporter in India
Competitive wholesale pricing
Authentic and certified products
Fast global shipping network
Reliable bulk supply for hospitals and distributors
Packaging & Strength
Strength: 100 mg
Form: Injection (IV infusion)
Packaging: Sterile vial
Contact for Bulk Orders & Export Inquiries
Partner with Cordium Pharmaceuticals Pvt Ltd for reliable oncology medicine supply and seamless international delivery.
